FDA PMA
FDA Class 3
30-Day Notice Accepted
🇺🇸 United States
Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor
PMA: P140015
·
Supplement: S022
·
Decision Jun 15, 2017
Classifications
1
FEI Numbers
8
Registration Numbers
8
Basic Information
- Device Name
- Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor
- Trade Name
- G4 Insulin Pump with Dexcom G4 Platinum CGM System
- PMA Number
- P140015
- Supplement Number
- S022
- Device Class
- FDA Class 3
- Product Code
- OYC
- Generic Name
- Pump, infusion, insulin, to be used with invasive glucose sensor
- Medical Specialty
- Unknown
- Advisory Committee
- Clinical Chemistry
- Decision
- 30-Day Notice Accepted
- Decision Code
- OK30
- Decision Date
- June 15, 2017
- Date Received
- May 16, 2017
- Supplement Type
- 30-Day Notice
- Supplement Reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Expedited Review
- N
Advisory Committee Statement
Modification to add a QC Manufacturing Aid to complement Quality Control acceptance review during the manufacturing of the t:slim G4 insulin pump, intended to be used with Dexcom G4 Continuous Glucose Monitoring (CGM) sensor and transmitter.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| OYC | Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor | FDA class 3 | Unknown |